BIOATLA, INC. Proceeds from Issuance of Convertible Preferred Stock
BIOATLA, INC. (BCAB) reported Proceeds from Issuance of Convertible Preferred Stock of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2022-02-28
- BIOATLA, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-12-31 was $0.00.
- BIOATLA, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2020-12-31 was -$4.10M.
- BIOATLA, INC. proceeds from issuance of convertible preferred stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BIOATLA, INC. proceeds from issuance of convertible preferred stock for fiscal 2020 was $68.18M.
- BIOATLA, INC. proceeds from issuance of convertible preferred stock for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 9 month | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $68.18M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $72.28M 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |